What is the Future of Enzyme Engineering in Neonatal Disorders?
The future of enzyme engineering in neonatal disorders looks promising, with ongoing advancements in biotechnology and molecular biology. Personalized medicine approaches are likely to emerge, where enzymes are tailored to the specific genetic makeup of individual patients. This could significantly improve treatment outcomes and reduce adverse effects. Moreover, interdisciplinary collaborations between fields such as bioinformatics, structural biology, and synthetic biology will likely accelerate the development of more effective and targeted enzyme-based therapies.
